Mainz Biomed N.V. (NASDAQ:MYNZ) shares, rose in value, with the stock price down by -4.66% to the previous day’s close as strong demand from buyers drove the stock to $0.86.
Actively observing the price movement in the last trading, the stock closed the session at $0.90. Referring to stock’s 52-week performance, its high was $6.00, and the low was $0.85. On the whole, MYNZ has fluctuated by -15.17% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MYNZ’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MYNZ currently trading nearly -13.57% and -13.45% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.06, while the 7-day volatility ratio is showing 12.93% which for the 30-day chart, stands at 8.82%. Furthermore, Mainz Biomed N.V. (MYNZ)’s beta value is 0.27, and its average true range (ATR) is 0.09.
A comparison of Mainz Biomed N.V. (MYNZ) with its peers suggests the former has fared considerably weaker in the market. MYNZ showed an intraday change of -4.66% in last session, and over the past year, it shrunk by -74.95%%.
Data on historical trading for Mainz Biomed N.V. (NASDAQ:MYNZ) indicates that the trading volumes over the past 3 months, they’ve averaged 81.95K. According to company’s latest data on outstanding shares, there are 21.17 million shares outstanding.
Nearly 21.68% of Mainz Biomed N.V.’s shares belong to company insiders and institutional investors own 1.39% of the company’s shares. The stock has fallen by -26.14% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MYNZ stock heading into the next quarter.
